Bad actors are using online ads, social media and bootleg ingredients to sell fake, inaccurate and harmful versions of these ...
We are now in the era of weight-loss drugs. Decisions on how these drugs will be used look likely to shape our future health and even what our society might look like. And, as researchers are finding, ...
America’s obesity rate looks to be plateauing—again.
New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.
On this week’s episode of Economic Update: how FED Chair Jerome Powell admits capitalism’s intrinsic instability, a Tennessee plastic plant won’t let workers leave before storm Helene hits, new drugs ...
This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.
The "takings clause" in the Fifth Amendment to the U.S. Constitution might keep the federal government from creating ...
Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United ...
CVS Health named David Joyner as its new chief, succeeding Karen Lynch at the helm of the struggling healthcare giant ...
Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...
GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...
Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback